Skip to main content

Table 2 Dosimetric data for neurological organs at risk

From: Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy

Organ at risk

Dmax (Gy)

D1 (Gy)

V45 Gy (%)

V54 Gy (%)

V57 Gy (%)

V60 Gy (%)

V65Gy (%)

Brainstem

55.9 (53.3–58.2)

53.3 (50.8–56.2)

/

1.1 (0–10.9)

0

0

0

Spinal cord

43.9 (41.0–45.7)

41.1 (36.9–44.0)

0

0

0

0

0

Optic chiasm

56.4 (43.1–59.6)

56.0 (41.9–59.5)

/

43.1 (0–98.8)

2.3 (0–47.8)

0

0

Optic nerve

 (A)

54.6 (42.4–60.1)

54.1 (41.9–59.5)

/

14.1 (0–51.9)

1.2 (0–17.3)

0

0

 (N)

54.5 (42.4–58.9)

53.9 (42.0–58.3)

/

9.9 (0–44.3)

0.1 (0–3.0)

0

0

Temporal lobe

 (A)

65.1 (60.4–68.4)

63.0 (58.3–65.8)

/

/

/

7.9 (0.1–49.9)

0.2 (0–1.9)

 (N)

64.7 (58.8–67.6)

61.9 (53.4–64.5)

/

/

/

4.2 (0–13.2)

0

  1. All values are presented as mean followed by range in parentheses
  2. D max maximum point dose, D 1 maximum dose to 1% of the volume, V x Gy percentage volume receiving a dose of x Gy or more, (x = 45, 54, 57, 60, and 65), / not applicable, A affected side, N unaffected side